Published in

BMJ Publishing Group, Journal of NeuroInterventional Surgery, 2(10), p. 107-111, 2017

DOI: 10.1136/neurintsurg-2017-012988

Links

Tools

Export citation

Search in Google Scholar

A decrease in blood pressure is associated with unfavorable outcome in patients undergoing thrombectomy under general anesthesia

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

BackgroundUp to two-thirds of patients are either dependent or dead 3 months after thrombectomy for acute ischemic stroke (AIS). Loss of cerebral autoregulation may render patients with AIS vulnerable to decreases in mean arterial pressure (MAP).ObjectiveTo determine whether a fall in MAP during intervention under general anesthesia (GA) affects functional outcome.MethodsThis subgroup analysis included patients from the MR CLEAN trial treated with thrombectomy under GA. The investigated variables were the difference between MAP at baseline and average MAP during GA (ΔMAP) as well as the difference between baseline MAP and the lowest MAP during GA (ΔLMAP). Their association with a shift towards better outcome on the modified Rankin Scale (mRS) after 90 days was determined using ordinal logistic regression with adjustment for prognostic baseline variables.ResultsSixty of the 85 patients treated under GA in MR CLEAN had sufficient anesthetic information available for the analysis. A greater ΔMAP was associated with worse outcome (adjusted common OR (acOR) 0.95 per point mm Hg, 95% CI 0.92 to 0.99). An average MAP during GA 10 mm Hg lower than baseline MAP constituted a 1.67 times lower odds of a shift towards good outcome on the mRS. For ΔLMAP this association was not significant (acOR 0.97 per mm Hg, 95% CI 0.94 to 1.00, p=0.09).ConclusionsA decrease in MAP during intervention under GA compared with baseline is associated with worse outcome.Trial registration numberNTR1804; ISRCTN10888758; post-results.